RECITALSTechnology Transfer and License Agreement • February 22nd, 2002 • Sonosite Inc • Surgical & medical instruments & apparatus
RECITALSTechnology Transfer and License Agreement • August 4th, 2000 • Arqule Inc • Pharmaceutical preparations • Delaware
TECHNOLOGY TRANSFER AND LICENSE AGREEMENT by and between Security Life of Denver Insurance Company ING North America Insurance CorporationTechnology Transfer and License Agreement • March 18th, 2005 • Scottish Re Group LTD • Life insurance • New York
TECHNOLOGY TRANSFER AND LICENSE AGREEMENT BY AND BETWEEN GENENTECH, INC., F. HOFFMANN-LA ROCHE LTD AND OCERA THERAPEUTICS, INC.Technology Transfer and License Agreement • May 30th, 2014 • Ocera Therapeutics, Inc. • Pharmaceutical preparations • Delaware
THIS TECHNOLOGY TRANSFER AND LICENSE AGREEMENT (“Agreement”) is made and entered into, effective as of December 13, 2013 (“Effective Date”), by and between Genentech, Inc., a Delaware corporation, having a principal place of business at 1 DNA Way, South San Francisco, California 94080 (“GNE”); F. Hoffmann-La Roche, Ltd, having a principal place of business at Grenzacherstrasse 124, CH 4070 Basel, Switzerland (“Roche”) (GNE and Roche, individually and collectively, referred to as “Licensee”); and Ocera Therapeutics, Inc., a Delaware corporation, having a principal place of business at 525 University Avenue, Suite 610, Palo Alto, California 94301 (“Ocera”). Licensee and Ocera are each referred to, individually, as a “Party” and, collectively, as the “Parties.”
DENOTES CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AMENDED AND RESTATED TECHNOLOGY TRANSFER AND LICENSE AGREEMENTTechnology Transfer and License Agreement • January 13th, 2009 • Micron Technology Inc • Semiconductors & related devices • Delaware
This AMENDED AND RESTATED TECHNOLOGY TRANSFER AND LICENSE AGREEMENT (this “Agreement”), is made and entered into as of this 26th day of November, 2008 (“Amendment Date”), by and between Micron Technology, Inc, a Delaware corporation (“Micron”), and Nanya Technology Corporation Nanya Technology Corporation [Translation from Chinese], a company incorporated under the laws of the Republic of China (“NTC”). (Micron and NTC are referred to in this Agreement individually as a “Party” and collectively as the “Parties”).
TECHNOLOGY TRANSFER AND LICENSE AGREEMENT This TECHNOLOGY TRANSFER AND LICENSE AGREEMENT, dated as of January 1, 1994, is between Sepracor Inc., a Delaware corporation ("Sepracor"), and BioSepra Inc., a Delaware corporation ("BioSepra"). R E C I T A L...Technology Transfer and License Agreement • March 31st, 1999 • Sepracor Inc /De/ • Pharmaceutical preparations • Massachusetts
Exhibit 10.2 TECHNOLOGY TRANSFER AND LICENSE AGREEMENTTechnology Transfer and License Agreement • January 24th, 1997 • Primex Technologies Inc • Search, detection, navagation, guidance, aeronautical sys • Illinois
ARTICLE I DEFINITIONS AND TERMSTechnology Transfer and License Agreement • February 7th, 2003 • Scansoft Inc • Services-prepackaged software • New York
TABLE OF CONTENTS ----------------- 1. DEFINITIONS...............................................................3Technology Transfer and License Agreement • December 6th, 1996 • Primex Technologies Inc • Search, detection, navagation, guidance, aeronautical sys • Illinois
Technology Transfer and License Agreement between Genentech, Inc. and Proteostasis Therapeutics, Inc.Technology Transfer and License Agreement • March 8th, 2019 • Proteostasis Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This Technology Transfer and License Agreement (“Agreement”) is made and entered into, effective as of December 13, 2018 (“Effective Date”), by and between Genentech, Inc., a Delaware corporation, having a principal place of business at 1 DNA Way, South San Francisco, California 94080 (“Genentech”) and Proteostasis Therapeutics, Inc. , a Delaware corporation, having a principal place of business at 80 Guest Street, Suite 500, Boston, MA 02135 (“PTI”). Genentech and PTI are each referred to herein individually as a “Party” and collectively as the “Parties.”
1 EXHIBIT 10.3 TECHNOLOGY TRANSFER AND LICENSE AGREEMENT THIS TECHNOLOGY TRANSFER AND LICENSE AGREEMENT (this "Agreement") is made as of the 1st day of June, 1999 (the "Effective Date") by and between Perfumania, Inc., a Florida corporation...Technology Transfer and License Agreement • June 4th, 1999 • Perfumania Com Inc • Florida
TECHNOLOGY TRANSFER AND LICENSE AGREEMENTTechnology Transfer and License Agreement • April 8th, 2013 • Micron Technology Inc • Semiconductors & related devices • Delaware
This THIRD AMENDED AND RESTATED TECHNOLOGY TRANSFER AND LICENSE AGREEMENT (this “Agreement”), is made and entered into as of this 17th day of January, 2013, by and between Micron Technology, Inc, a Delaware corporation (“Micron”), and Nanya Technology Corporation (Nanya Technology Corporation [Translation from Chinese]), a company incorporated under the laws of the Republic of China (“NTC”). (Micron and NTC are referred to in this Agreement individually as a “Party” and collectively as the “Parties”).
TECHNOLOGY TRANSFER AND LICENSE AGREEMENT FOR 68-50nm PROCESS NODESTechnology Transfer and License Agreement • July 8th, 2008 • Micron Technology Inc • Semiconductors & related devices • Delaware
This TECHNOLOGY TRANSFER AND LICENSE AGREEMENT FOR 68-50nm PROCESS NODES (this “Agreement”), is made and entered into as of this 21st day of April, 2008 (“Effective Date”), by and between Micron Technology, Inc., a Delaware corporation (“Micron”), and Nanya Technology Corporation (Nanya Technology Corporation [Translation from Chinese]), a company incorporated under the laws of the Republic of China (“NTC”). (Micron and NTC are referred to in this Agreement individually as a “Party” and collectively as the “Parties”).
Confidential AMENDMENT NUMBER 1 TO TECHNOLOGY TRANSFER AND LICENSE AGREEMENT dated as of January 1, 1993Technology Transfer and License Agreement • November 2nd, 2015 • Mesoblast LTD • Biological products, (no disgnostic substances)
This Amendment Number 1 is effective as of the date of last signature and is entered into by and between Osiris Therapeutics, Inc., a corporation of the State of Ohio, having a place of business at 2001 Aliceanna Street, Baltimore, Maryland 21231 (hereinafter referred to as “Osiris”), and Case Western Reserve University, an Ohio non-profit Corporation having its principle office at 10900 Euclid Avenue, Cleveland, Ohio 44106 (hereinafter referred to as “CWRU”).
TECHNOLOGY TRANSFER AND LICENSE AGREEMENT Between CASE WESTERN RESERVE UNIVERSITY and OSIRIS THERAPEUTICS, INC. This agreement effective as of the 1st day of January, 1993 ("Effective Date"), is between OSIRIS THERAPEUTICS, Inc., corporation domiciled...Technology Transfer and License Agreement • August 13th, 1997 • Osiris Therapeutics Inc • Services-medical laboratories • Ohio
INTRODUCTIONTechnology Transfer and License Agreement • July 30th, 1999 • Millennium Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
CELL TECHNOLOGY TRANSFER AND LICENSE AGREEMENTTechnology Transfer and License Agreement • November 6th, 2012 • Fuelcell Energy Inc • Miscellaneous electrical machinery, equipment & supplies • New York
THIS CELL TECHNOLOGY TRANSFER AND LICENSE AGREEMENT (this “Agreement”) is made and entered into this 31st day of October, 2012, by and between FUELCELL ENERGY, INC., a Delaware corporation having a place of business at 3 Great Pasture Rd., Danbury, CT 06813, U.S.A. (“FCE”) and POSCO ENERGY CO., LTD. (formerly POSCO POWER), a Korean corporation having a place of business at POSCO Center, 440 Teheran-ro, Gangnam-gu, Seoul 135-777, Korea (“POSCO Energy”).
TECHNOLOGY TRANSFER AND LICENSE AGREEMENT Between CASE WESTERN RESERVE UNIVERSITY and OSIRIS THERAPEUTICS, INC.Technology Transfer and License Agreement • June 20th, 2006 • Osiris Therapeutics, Inc. • Biological products, (no disgnostic substances) • Ohio
This Agreement, effective as of the 1st day of January, 1993 (“Effective Date”), is between OSIRIS THERAPEUTICS, Inc., a corporation domiciled in the State of Ohio having an address at 11000 Cedar Avenue, Cleveland, OH 44106 (“OSIRIS”), and Case Western Reserve University, an Ohio non-profit corporation having its principal office at 2040 Adelbert Road, Cleveland, Ohio (“CWRU”).
TECHNOLOGY TRANSFER AND LICENSE AGREEMENTTechnology Transfer and License Agreement • February 25th, 2005 • Jmar Technologies Inc • Measuring & controlling devices, nec • California
THIS TECHNOLOGY TRANSFER AND LICENSE AGREEMENT (the “Agreement”), is entered into on February 21, 2005 (the “Effective Date”), by and between JMAR Technologies, Inc., a Delaware corporation, and Gregory M. Quist (“Quist”) and David A. Drake (“Drake”) doing business as The LXT Group. The parties agree as follows:
EXHIBIT 10.2 TECHNOLOGY TRANSFER AND LICENSE AGREEMENT THIS LICENSE AGREEMENT (the "Agreement") is effective as of April 6, 1998 (the "Effective Date"), and is by and between: (i) ATL Ultrasound, Inc., a corporation of the State of Washington doing...Technology Transfer and License Agreement • March 31st, 1998 • Sonosight Inc • Surgical & medical instruments & apparatus • Washington
EXHIBIT 10.2 TECHNOLOGY TRANSFER AND LICENSE AGREEMENT THIS LICENSE AGREEMENT (the "Agreement") is effective as of April 6, 1998 (the "Effective Date"), and is by and between: (i) ATL Ultrasound, Inc., a corporation of the State of Washington doing...Technology Transfer and License Agreement • March 19th, 1998 • Sonosight Inc • Surgical & medical instruments & apparatus • Washington
CONFIDENTIAL TREATMENT REQUESTED BY ALIEN TECHNOLOGY CORP. TECHNOLOGY TRANSFER AND LICENSE AGREEMENTTechnology Transfer and License Agreement • June 16th, 2006 • Alien Technology Corp • Electronic components, nec
This Technology Transfer and License Agreement (“AGREEMENT”) is made between North Dakota State University (hereinafter “NDSU”) and ALIEN Technology Corporation (hereinafter “ALIEN”). This Agreement shall be effective as of the 17th day of June, 2002 (“EFFECTIVE DATE”).
CONFIDENTIAL TREATMENT REQUESTED BY ALIEN TECHNOLOGY CORP. TECHNOLOGY TRANSFER AND LICENSE AGREEMENTTechnology Transfer and License Agreement • April 13th, 2006 • Alien Technology Corp
This Technology Transfer and License Agreement (“AGREEMENT”) is made between North Dakota State University (hereinafter “NDSU”) and ALIEN Technology Corporation (hereinafter “ALIEN”). This Agreement shall be effective as of the 17th day of June, 2002 (“EFFECTIVE DATE”).
Confidential AMENDMENT NUMBER 1 TO TECHNOLOGY TRANSFER AND LICENSE AGREEMENT dated as of January 1, 1993Technology Transfer and License Agreement • December 10th, 2014 • Mesoblast LTD • Biological products, (no disgnostic substances)
This Amendment Number 1 is effective as of the date of last signature and is entered into by and between Osiris Therapeutics, Inc., a corporation of the State of Ohio, having a place of business at 2001 Aliceanna Street, Baltimore, Maryland 21231 (hereinafter referred to as “Osiris”), and Case Western Reserve University, an Ohio non-profit Corporation having its principle office at 10900 Euclid Avenue, Cleveland, Ohio 44106 (hereinafter referred to as “CWRU”).
AMENDMENT TO THE TECHNOLOGY TRANSFER AND LICENSE AGREEMENT BETWEEN CASE WESTERN RESERVE UNIVERSITY AND OSIRIS THERAPEUTICS, INC.Technology Transfer and License Agreement • December 10th, 2014 • Mesoblast LTD • Biological products, (no disgnostic substances)
This Amendment, effective as of the day of October, 1999, “Amendment Effective Date” between Osiris Therapeutics, Inc. (“OSIRIS”) and Case Western Reserve University (“CWRU”).
CELL TECHNOLOGY TRANSFER AND LICENSE AGREEMENT dated as of October 31, 2012 between FUELCELL ENERGY, INC. and POSCO ENERGY CO., LTD.Technology Transfer and License Agreement • January 7th, 2013 • Fuelcell Energy Inc • Miscellaneous electrical machinery, equipment & supplies • New York
THIS CELL TECHNOLOGY TRANSFER AND LICENSE AGREEMENT (this “Agreement”) is made and entered into this 31st day of October, 2012, by and between FUELCELL ENERGY, INC., a Delaware corporation having a place of business at 3 Great Pasture Rd., Danbury, CT 06813, U.S.A. (“FCE”) and POSCO ENERGY CO., LTD. (formerly POSCO POWER), a Korean corporation having a place of business at POSCO Center, 440 Teheran-ro, Gangnam-gu, Seoul 135-777, Korea (“POSCO Energy”).
Technology Transfer and License AgreementTechnology Transfer and License Agreement • December 15th, 2010 • Net Element, Inc. • Crude petroleum & natural gas • Florida
THIS TECHNOLOGY TRANSFER AND LICENSE AGREEMENT ("the Agreement") effective as of December 14, 2010 (the “Effective Date”) is entered into by and between NETLAB SYSTEMS, LLC, with its principal office at 1450 South Miami Avenue, Miami, Florida 33130 (“Netlab”) and OPENFILM, LLC, with its principal office at 1450 South Miami Avenue, Miami, Florida 33130 ("Openfilm").
TECHNOLOGY TRANSFER AND LICENSE AGREEMENT BY AND BETWEEN GENENTECH, INC., F. HOFFMANN-LA ROCHE LTD AND OCERA THERAPEUTICS, INC.Technology Transfer and License Agreement • February 24th, 2014 • Ocera Therapeutics, Inc. • Pharmaceutical preparations
THIS TECHNOLOGY TRANSFER AND LICENSE AGREEMENT (“Agreement”) is made and entered into, effective as of December 13, 2013 (“Effective Date”), by and between Genentech, Inc., a Delaware corporation, having a principal place of business at 1 DNA Way, South San Francisco, California 94080 (“GNE”); F. Hoffmann-La Roche, Ltd, having a principal place of business at Grenzacherstrasse 124, CH 4070 Basel, Switzerland (“Roche”) (GNE and Roche, individually and collectively, referred to as “Licensee”); and Ocera Therapeutics, Inc., a Delaware corporation, having a principal place of business at 525 University Avenue, Suite 610, Palo Alto, California 94301 (“Ocera”). Licensee and Ocera are each referred to, individually, as a “Party” and, collectively, as the “Parties.”
